Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sentivity of urinary cytology in transitional cell carcinoma of the bladder

Journal of Urology

Volumn 159, Issue 2, 1998, Pages 384-388

  Planz, Bernhard ^a   Striepecke, Ellen ^b   Jakse, Gerhard ^b   Böcking, Alfred ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NONE

Author keywords

Bladder neoplasms; Cytology; DNA; Flow cytometry; Stage specific embryonic antigen 1

Indexed keywords

DNA; STAGE SPECIFIC EMBRYO ANTIGEN 1;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD GROUP LEWIS SYSTEM; CLINICAL ARTICLE; CYTODIAGNOSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMAGE CYTOMETRY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0031985161     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63926-0     Document Type: Article

References (39)

1. Amberson, J. B. and Laino, J. P.: Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma. J. Urol., 149: 42, 1993.
2. Beyer Boon, M. E., de Voogt, H. J., Vandervelde, E. A., Brussee, J. A. M. and Schaberg, A.: The efficiacy of urinary cytology in the detection of urothelial tumors-sensitivity and specificity of urinary cytology. Urol. Res., 6: 3, 1993.
3. Collste, L. G., Devonec, M., Darzynkiewicz, Z., Traganos, F., Sharpless, T. K., Whitmore, W. F. and Melamed, M. R.: Bladder cancer diagnosis by flow cytometry, correlation between cell samples from biopsy and bladder irrigation fluid. Cancer, 45: 2389, 1980.
4. Fehrmann-Zumpe, P. J., Klebingat, K. J. and Lorenz, G.: Die Urinzytologie als Screening. Urologe B, 32: 262, 1992.
5. Jakse, G., Hofstädter, F. and Marberger, H.: Wert der Harnzytologie und Quadrantenbiopsie bei oberflächlichen Blasenkarzinomen. Akt. Urol., 4: 309, 1980.
6. Murphy, W. H., Emerson, L. D., Chandlers, R. W., Moinuddin, S. M. and Soloway, M. S.: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J. Urol., 136: 815, 1986.
7. Rübben, H., Rathert, P., Roth, S. T., Hofstädter, F., Giani, G., Terhorst, B. and Friedrichs, R.: Exfoliative Urinzytologie. 4. Auflage Harnwegstumorregister, Fort-und Weiterbildungskomission der Deutschen Urologen, Arbeitskreis Onkologie, Sektion Urinzytologie. Essen Selbstverlag, 1989.
8. Badalament, R. A., Gag, H., Whitmore, W. F., Herr, H. W., Fair, W. R., Oettgen, H. F. and Melamed, M. R.: Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry. Cancer, 8: 2751, 1986.
9. Badalament, R. A., Hermansen, D. K., Kimmel, M., Gay, H., Herr, H. W., Fair, W. R., Whitmore, W. F. and Melamed, M. R.: The sensitivity of bladder wash flow cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma. Cancer, 60: 1423, 1987.
10. Koss, L. G., Deitch, D., Ramanathan, A. B. and Sherman, A. B.: Diagnostic value of cytology of voided urine. Acta Cytol., 9: 810, 1985.
11. Tanaka, K., Takashi, M., Sahashi, M., Shimoji, T., Miyake, K., Koshikawa, T., Shirai, T., Kawashima, K. and Nakajima, N.: Clinical study of urinary cytology in bladder tumors. Acta Urol. Jap., 36: 7, 1990.
12. Wiener, H. G., Voojis, G. P. and van 't Hof-Grotenboer, B.: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol., 37: 163, 1993.
13. van der Poel, H. G., Schaafsma, H. E., Voijs, G. P., Debruyne, F. M. J. and Schalken, J. A.: Quantitative light microscopy in urologic oncology. J. Urol., 148: 1, 1992.
14. Cajulis, R. S., Haines, G. K., Frias-Hedwegi, D., McVary, K. and Bacus, J. W.: Cytology, flow cytometry, image analysis and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn. Cytopath., 13: 214, 1995.
15. Chin, J. L., Hben, P. R., Nava, E., Rustum, Y. M., Greco, J. M., Pontes, E. and Frankfurt, O. S.: Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids. Cancer, 56: 1677, 1985.
16. Hofstädter, F., Jakse, G., Lederer, B., Mikuz, G. and Delgado, R.: Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma. Brit. J. Urol., 56: 289, 1984.
17. Leyh, H., Valet, G. and Lehmer, A.: Einsatz der Mehrparameter-Durchflußzytometrie zur automatischen Identifizierung maligner Blasentumorzellen. Akt. Urol., 22: 157, 1991.
18. Oljans, P. J. and Tanke, H. J.: Flow cytometric analysis of DNA-content in bladder cancer: prognostic value of the DNA-index with respect to early tumor recurrence in G2 tumours. World J. Urol., 4: 205, 1986.
19. Tribukait, B., Gustafson, H. and Eposti, P. L.: The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Brit. J. Urol., 54: 130, 1982.
20. Böcking, A., Giroud, F. and Reith, A.: Consensus report of the ESACP task force on standardization of diagnostic DNA image cytometry. Anal. Cell. Path., 8: 67, 1995.
21. Wheeles, L. L., Badalament, R. A., deVere White, R. W., Fradet, Y. and Tribukait, B.: Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry, 14: 478, 1993.
22. Planz, B., Striepecke, E., Robben, J., Jakse, G. and Böcking, A.: Image cytometric DNA analysis in transitional cell carcinoma of the urinary bladder. J. Urol., part 2, 153: 458A, 1995.
23. Planz, B., Striepecke, E., Wolff, J. M., Effert, P., Jakse, G. and Böcking, A.: DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas. Gen. Path., 142: 69, 1996.
24. Cordon-Cardo, C., Lloyd, K. O., Finstad, C. L., McGroarty, M. R., Reuter, V. E., Bander, N. H., Old, L. J. and Melamed, M. R.: Immunoanatomic distribution of blood group antigens in human urinary tract. Influence of secretory status. Lab. Invest., 55: 444, 1986.
25. Rettig, W. J., Cordon-Cardo, C., Ng, J. S., Oettgen, H. F., Old, J. and Lloyd, K. O.: High molecular weight glycoproteins human teratocarcinoma defined by monoclonal antibodies carbohydrate determinants. Cancer Res., 45: 815, 1985.
26. Cordon-Cardo, C., Reuter, V. E., Lloyd, K. O., Sheinfeld, J., Fair, W. R., Old, L. J. and Melamed, M. R.: Blood group related antigens in human urothelium: enhanced expression of precursor, Le x and Le y determinants in urothelial carcinoma. Cancer Res., 48: 4113, 1988.
27. Böcking, A.: DNA-measurements. When and Why? In: Compendium on Quality Assurance, Proficiency Testing and Workload Limitations, Clinical Cytology. Tutorials of Cytology. Edited by G. L. Wied, P. H. Barthels, D. L. Rosenthal and U. Schenk. Chicago: pp. 170-188, 1995.
28. Chatelain, R., Willms, A., Biesterfeld, S., Auffermann, W. and Böcking, A.: Automated Feulgen staining with a temperature-controled staining machine. Anal. Quant. Cytol., 3: 211, 1989.
29. Böcking, A., Striepecke, E., Auer, H. and Füzesi, L.: Static DNA cytometry. In: Compendium on the Computerized Cytology and Histology Labaratory, Tutorials of Cytology. Edited by G. L. Wied, P. H. Barthels, D. L. Rosenthal and U. Schenck, Chicago: pp. 107-128, 1994.
30. Auer, H., Kropff, M., Müller, W., Sommer, B. and Böcking, A.: PC-based, semi-expert cytometric system as a diagnostic aid in clinical routine pathology. Anal. Cell. Path., 4: 128, 1992.
31. Müller, H. W., Böcking, A. and Auer, H.: TV Cytometer CM 1 for computer aided tumor diagnosis. In: Compendium on the Computerized Cytology and Histology Labaratory, Tutorials of Cytology. Edited by G. L. Wied, P. H. Barthels, D. L. Rosenthal, U. Schenck, Chicago: pp. 376-388, 1994.
32. Böcking, A.: Diagnostic DNA cytometry of the urothelium. In: Urinary Cytology Manual and Atlas. Edited by P. Rathert, S. Roth and M. S. Soloway, New York: Springer-Verlag, pp. 147-164, 1991.
33. Coon, J. S. and Weinstein, R. S.: Blood group related antigen markers of malignant potential and heterogeneity in human carcinomas. Hum. Path., 17: 1089, 1986.
34. Hakomori, S.: Aberrant glycosilation in cancer cell membranes focused on glycolipids: overview and perspectives. Cancer Res., 45: 2405, 1985.
35. Liu, B., Neuwirth, H., Zhu, L. W., Stock, L. M., de Kernig, J. B. and Fahey, J. L.: Detection of oncofetal bladder antigen in urine of patients with transitional cell carcinoma. J. Urol., 137: 1258, 1987.
36. Sagerman, P. M., Saigo, P. E., Sheinfield, L., Caritonowics, E. and Cordon-Cardo, C.: Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens. Acta Cytol., 38: 517, 1994.
37. Sheinfeld, J., Reuter, V., Melamed, M. R., Fair, W. R., Morse, M., Sogani, P., Herr, H., Whitmore, W. and Cardon-Cardo, C.: Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J. Urol., 143: 285, 1990.
38. Huland, E., Huland, H. and Schneider, A. W.: Quantitative immunocytology in the management of patients with superficial bladder carcinoma. A marker to identify patients who do not require prophylaxis. J. Urol., 144: 637, 1990.
39. Golijanin, D., Sherman, Y., Shapiro, A. and Pode, D.: Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine. Urology, 46: 173, 1995.